Novartis (NVS) slides as Q4 EPS, revenue miss estimates
January 31, 2024 7:30 AM
Novartis (NYSE: NVS) stock fell 4% in premarket trading Wednesday after the Swiss pharmaceutical company reported worse-than-expected core earnings for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
